INFLAMACORE Trademark

Trademark Overview

On Monday, September 30, 2019, a trademark application was filed for INFLAMACORE with the United States Patent and Trademark Office. The USPTO has given the INFLAMACORE trademark a serial number of 88636871. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, October 16, 2024. This trademark is owned by InflamaCORE, LLC. The INFLAMACORE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biotechnology research
inflamacore

General Information

Serial Number88636871
Word MarkINFLAMACORE
Filing DateMonday, September 30, 2019
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateWednesday, October 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 19, 2024

Trademark Statements

Pseudo MarkINFLAMMASOME CORE; INFLAMMATORY CORE; INFLAMA CORE
Goods and ServicesBiotechnology research

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 4, 2019
Primary Code042
First Use Anywhere DateFriday, March 1, 2013
First Use In Commerce DateFriday, March 1, 2013

Trademark Owner History

Party NameInflamaCORE, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMiami, FL 33156

Trademark Events

Event DateEvent Description
Thursday, October 3, 2019NEW APPLICATION ENTERED
Friday, October 4, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 2, 2020ASSIGNED TO EXAMINER
Friday, January 10, 2020NON-FINAL ACTION WRITTEN
Friday, January 10, 2020NON-FINAL ACTION E-MAILED
Friday, January 10, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 10, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 10, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, July 11, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 13, 2020SUSPENSION LETTER WRITTEN
Monday, July 13, 2020LETTER OF SUSPENSION E-MAILED
Monday, July 13, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, July 14, 2020TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, July 28, 2020ASSIGNED TO LIE
Saturday, August 1, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, August 1, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 3, 2020SUSPENSION LETTER WRITTEN
Monday, August 3, 2020LETTER OF SUSPENSION E-MAILED
Monday, August 3, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, July 6, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, January 24, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, July 27, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, March 20, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, December 12, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, October 7, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, October 9, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 13, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Related Keywords

inflamacore research biotechnology